DOYLESTOWN, Pa., Aug. 16, 2017 -- Alamo Pharma Services, an established leader in attracting exceptional talent in the pharmaceutical and biotech industries, has formed a specialized division of the company that offers partner organizations recruiting services to place the right people with the right attitude and the right talent in the right position within the client company.
|
||||||||
“The investment companies make in bringing products to market is not fully realized until they put that product in the best position to be promoted to healthcare providers,” says Amy Peek, Alamo’s Executive Director, Talent Management and Growth. “Alamo can help in all aspects of recruitment to ensure that our clients have the representatives and sales leaders they need to increase sales and maximize their brand’s opportunity.”
Alamo’s recruiting experts work side by side with clients to provide a thoughtful, customized approach that follows behavioral models to ensure that the new hire is a perfect fit for both the job and company’s culture. Like any true partner, Alamo Recruitment Services stays integrally involved in the onboarding of new talent – a key step in boosting profitability and escalating growth.
“The foundation of pharmaceutical and biotech commercial organizations is its sales team,” says Peter Marchesini, Alamo Chief Operating Officer. “Establishing a best-in-class talent acquisition process ensures that you are getting the best possible person for your sales team. Alamo has an exceptional group of recruiting professionals in place who understand and embrace the challenges of today’s market. They are acutely knowledgeable about the pharmaceutical sales industry to better ensure successful results, not only to fill a role but for long-term success.”
Companies seeking a customized talent acquisition organization to attract and retain exceptional talent in the consistently changing pharmaceutical and biotech industries are encouraged to contact Alamo Recruitment Services via email at [email protected].
About Alamo Pharma Services
Founded in 2011, Alamo Pharma Services offers pharmaceutical and biotech companies vital solutions to bring their products to market efficiently and successfully. Based out of its offices in Doylestown, Pa., Alamo offers companies vast commercialization experience, customized recruiting of sales teams, superior training, and committed support services. For more information regarding Alamo, visit AlamoPharmaServices.com or email [email protected].
Alamo is a part of the Mission Family of Companies, a collection of wholly-owned subsidiaries created to diversify offerings and build forward-thinking partnerships with other pharmaceutical and biotech companies. Each company functions independently while their product and service offerings can be linked together to offer customizable solutions to a wide array of outside companies. Other Mission companies include BioComp Pharma, Inc., a generic drug marketer; ProSolus, Inc., a transdermal drug developer and manufacturer; Espada Dermatology, Inc., a prescription and esthetic dermatology company; as well as BexR Logistix, LLC and their subsidiary company, EPIC Fulfillment, Inc., the logistics and fulfillment arms of Mission. To learn more, please visit missionfamilyofcompanies.com.
# # #
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/410950d3-5bb5-45f6-a201-919dd23293ce
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/b2bab804-58fa-4995-bdc8-205903e97bba
Drew Deeter Alamo Pharma Services 215.348.3890 [email protected]


Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Shell M&A Chief Exits After BP Takeover Proposal Rejected
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation
noyb Files GDPR Complaints Against TikTok, Grindr, and AppsFlyer Over Alleged Illegal Data Tracking.
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Robinhood Expands Sports Event Contracts With Player Performance Wagers
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround 



